Bitop AG   Report issue

For profit
Founded: Witten Germany (1993)
Status: No NME R&D (1993)

Organization Overview

First Clinical Trial
2011
NCT02133053
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Bitop AG

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 7